GENER8 MARITIME,INC. (NYSE:GNRT) Files An 8-K Other EventsItem 8.01 Other Events.
As described in greater detail in the proxy statement/prospectus filed by Gener8 Maritime,Inc. (“Gener8”) with the Securities and Exchange Commission (the “SEC”) on May10, 2018, two lawsuits (the “Actions”), captioned Fragapane v. Gener8 Maritime,Inc. et al., No.1:18-cv-02097 (S.D.N.Y.) and Mohr v. Gener8 Maritime,Inc., et al., No.1:18-cv-02276 (S.D.N.Y.), have been filed in the United States District Court for the Southern District of New York against Gener8, Gener8’s current directors and one of its former directors, Euronav NV (“Euronav”) and Euronav MI Inc. The complaints challenge Gener8’s proposed merger (the “Merger”) with Euronav, to the Agreement and Plan of Merger, dated December20, 2017, among Euronav, Euronav MI Inc., and Gener8 (the “Merger Agreement”).
The defendants believe that the claims asserted in the Actions are without merit and no supplemental disclosure is required under applicable law. To the contrary, the defendants specifically deny all allegations in the Actions. However, on May11, 2018, in order to avoid the risk of adverse effect or delay in connection with the transaction and to minimize the costs, risks and uncertainties inherent in litigation, and without admitting any liability or wrongdoing, the defendants entered into a memorandum of understanding (the “MOU”) with plaintiffs memorializing the parties’ agreement to settle the Actions. Under the terms of the MOU, the plaintiffs have agreed to voluntarily dismiss with prejudice their individual claims asserted in the Actions, and dismiss without prejudice claims asserted in the Fragapane action on behalf of a putative class of Gener8 shareholders, and to undertake all steps, including the preparation and filing of documents, stipulations or other papers deemed necessary to effectuate dismissal of the Actions. In connection with the settlement, plaintiffs intend to seek an award of attorneys’ fees and reimbursement of expenses.
In connection with the settlement, the defendants also agreed to supplemental disclosures (the “Supplemental Disclosures”) included in amendments to Euronav’s registration statement on FormF-4, filed with the SEC on March30, 2018 and April24, 2018. The Supplemental Disclosures include disclosures that address plaintiffs’ allegations and claims that the registration statement on FormF-4 was misleading and incomplete and were made solely to avoid the costs and burdens of litigation, and without admitting any liability or wrongdoing.
The settlement will not affect the merger consideration to be paid to Gener8 shareholders in connection with the Merger, or the timing of the special meeting of Gener8 shareholders to vote on the Merger Agreement.
Cautionary Statement Regarding Forward-Looking Statements
This Form8-K, including information incorporated by reference into this Form8-K, may contain forward-looking statements, including, for example, but not limited to, statements about management expectations, strategic objectives, strategic opportunities, growth opportunities, business prospects, regulatory proceedings, transaction synergies and other benefits of the Merger, and other similar matters. Forward-looking statements are not statements of historical facts and represent only Euronav’s or Gener8’s beliefs regarding future events, which are inherently uncertain. Forward-looking statements are typically identified by words such as “anticipates,” “believes,” “budgets,” “could,” “estimates,” “expects,” “forecasts,” “foresees,” “goal,” “intends,” “likely,” “may,” “might,” “plans,” “projects,” “schedule,” “should,” “target,” “will,” or “would” and similar expressions, although not all forward-looking information contains these identifying words.